Presentación    
GROUP 19.
IMMUNO-RHEUMATOLOGY
Publications
YEAR NAME I.F. CUARTILE
2011 Haraoui, B.; Smolen, J. S.; Aletaha, D.; Breedveld, F. C.; Burmester G.; Codreanu, C.; Da Silva, J. P.; de Wit, M.; Dougados, M.; Durez, P.; Emery, P.; Fonseca, J. E.; Gibofsky, A.; Gómez-Reino, J.; Graninger, W.; Hamuryudan, V.; Pena, M. J. J.; Kalden, J.; Kvien, T. K.; Laurindo, I.; Martín-Mola, E.; Montecucco, C.; Moreno, P. S.; Pavelka, K.; Poor, G.; Cardiel, M. H.; Stanislawska-Biernat, E.; Takeuchi, T.; van der Heijde, D. Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(11): 1999-2002. 8,727 D1
2011 Buch, M. H.; Smolen, J. S; Betteridge, N.; Breedveld, F. C.; Burmester,
G.; Dorner, T.; Ferraccioli, G.; Gottenberg, J. E.; Isaacs, J.; Kvien, T. K.; Mariette, X.; Martín-Mola, E.; Pavelka, K.; Tak, P. P.; van der Heijde, D.; van Vollenhoven, R. F; Emery, P. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(6): 909-920. Review.
8,727 D1
2011 Felson, D. T.; Smolen, J. S.; Wells, G.; Zhang, B.; van Tuyl, L. H. D.;
Funovits, J.; Aletaha, D.; Allaart, C. F.; Bathon, J.; Bombardieri, S.;
Brooks, P.; Brown, A.; Matucci-Cerinic, M.; Choi, H.; Combe, B.;
de Wit, M.; Dougados, M.; Emery, P.; Furst, D.; Gómez-Reino,
J.; Hawker, G. American College of Rheumatology, European
League Against Rheumatism Provisional Definition of Remission
in Rheumatoid Arthritis for Clinical Trials. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(3): 404-413. Article.
8,727 D1
2011 Gossec, L.; Bijlsma, J. W. J.; Bombardier, C.; Canhao, H.; Devlin,
J.; Edwards, C. J.; Hamuryudan, V.; Kvien, T. K.; Leeb, B. F.; Martín-
Mola, E. M.; Mielants, H.; Muller-Ladner, U.; Ostergaard, M.; Pereira,
I. A.; Ramos-Remus, C.; Zochling, J.; Dougados, M. Dissemination
and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(2): 388-U180. Letter.
8,727 D1
2011 Machado, P.; Castrejón, I.; Katchamart, W.; Koevoets, R.; Kuriya,
B.; Schoels, M.; Silva-Fernández, L.; Thevissen, K.; Vercoutere, W.;
Villeneuve, E.; Aletaha, D.; Carmona, L.; Landewe, R.; van der Heijde,
D.; Bijlsma, J. W. J.; Bykerk, V.; Canhao, H.; Catrina, A. I.; Durez, P. Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(1): 15-24. Review.
8,727 D1
2011 García-Arias, M.; Balsa, A.; Mola, E. M. Septic arthritis. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. 2011; 25(3): 407-421. Article. 2,653 Q2
2011 Navarro-Sarabia, F.; Fernández-Sueiro, J. L.; Torre-Alonso, J. C.;
Gratacos, J.; Queiro, R.; González, C.; Loza, E.; Linares, L.; Zarco, P.; Juanola, X.; Roman-Ivorra, J.; Martín-Mola, E.; Sanmarti, R.; Mulero,
J.; Díaz, G.; Armendáriz, Y.; Collantes, E. High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study). RHEUMATOLOGY.
2011; 50(10): 1828-2837. Article.
4,058 Q2
2011 Pascual-Salcedo, D.; Plasencia, C.; Ramiro, S.; Nuno, L.; Bonilla, G.;
Nagore, D.; del Agua, A. R.; Martínez, A.; Aarden, L.; Martín-Mola, E.;
Balsa, A. Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis. RHEUMATOLOGY. 2011; 50(8): 1445-1452. Article.
4,058 Q2
2011 Martín-Mola, E.; Gómez-Carrera, L. The impact of a jointly staffed
clinic on the diagnosis of lung involvement and connective tissue diseases. RHEUMATOLOGY. 2011; 50(3): 434-436. Editorial Material.
4,058 Q2
2011 Gossec, L.; Paternotte, S.; Aanerud, G. J.; Balanescu, A.; Boumpas, D.
T.; Carmona, L.; de Wit, M.; Dijkmans, B. A. C.; Dougados, M.; Englbrecht, M.; Gogus, F.; Heiberg, T.; Hernandez, C.; Kirwan, J. R.; Mola, E. M.; Cerinic, M. M.; Otsa, K.; Schett, G.; Scholte-Voshaar, M.; Sokka, T.; von Krause, G.; Wells, G. A.; Kvien, T. K. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(6): 935-942. Article.
8,727 D1
2011 Burmester, G.; Lanas, A.; Biasucci, L.; Hermann, M.; Lohmander, S.;
Olivieri, I.; Scarpignato, C.; Smolen, J.; Hawkey, C.; Bajkowski, A.; Berenbaum, F.; Breedveld, F.; Dieleman, P.; Dougados, M.; MacDonald, T.; Mola, E. M.; Mets, T.; Van den Noortgate, N.; Stoevelaar, H. The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(5): 818-822. Article.
8,727 D1
2011 Felson, D. T.; Smolen, J. S.; Wells, G.; Zhang, B.; van Tuyl, L. H.. D.; Funovits, J.; Aletaha, D.; Allaart, C. F.; Bathon, J.; Bombardieri, S.; Brooks, P.; Brown, A.; Matucci-Cerinic, M.; Choi, H.; Combe, B.; de Wit, M.; Dougados, M.; Emery, P.; Furst, D.; Gómez-Reino, J.; Hawker, G. American College of Rheumatology, European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials ARTHRITIS AND RHEUMATISM. 2011; 63(3): 573-586. Article. 7,866 Q1
2011 Bonilla-Hernán, M. G.; Miranda-Carús, M. E.; Martín-Mola, E. New
drugs beyond biologics in rheumatoid arthritis: the kinase inhibitors.
RHEUMATOLOGY. 2011; 50(9): 1542-1550. Review.
4,058 Q2
2011 Varade, J.; Palomino-Morales, R.; Ortego-Centeno, N.; Díaz-Rubio,
M.; Fernández-Gutiérrez, B.; González-Gay, M. A.; Pascual-Salcedo,
D.; Balsa, A.; Iglesias, A.; Gómez-García, M.; Witte, T.; Radstake, T. R.
D. J.; Coenen, M. J. H.; Urcelay, E.; Martín, J. Analysis of the REL polymorphism rs13031237 in autoimmune diseases. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(4): 711-U206. Letter.
8,727 D1
2011 Dawidowicz, K.; Allanore, Y.; Guedj, M.; Pierlot, C.; Bombardieri, S.;
Balsa, A.; Westhovens, R.; Barrera, P.; Alves, H.; Teixeira, V. H.; Petit-
Teixeira, E.; van de Putte, L.; van Riel, P.; Prum, B.; Bardin, T.; Meyer,
O.; Cornelis, F.; Dieude, P (Pascuale-Salcedo, D.; Balsa, A.). The interferon regulatory factor 5 gene confers susceptibility to rheumatoid
arthritis and influences its erosive phenotype. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(1): 117-121. Article.
8,727 D1
2011 Rodríguez-Rodríguez, L.; Taib, W. R. W.; Topless, R.; Steer, S.; González-Escribano, M. F.; Balsa, A.; Pascual-Salcedo, D.; González-Gay, M.A.; Raya, E.; Fernández-Gutiérrez, B; González-Álvaro, I.; Bottini, N.; Witte, T.; Viken, M. K.; Coenen, M. J. H.; van Riel, P. L. C. M. ; Franke, B. The PTPN22 R263Q Polymorphism Is a Risk Factor for Rheumatoid Arthritis in Caucasian Case-Control Samples. ARTHRITIS AND RHEUMATISM. 2011; 63(2): 365-372. Article. 7,866 Q1
2011 Teruel, M.; Martín, J. E.; González-Juanatey, C.; López-Mejías, R.; Miranda-Filloy, J. A.; Blanco, R.; Balsa, A.; Pascual-Salcedo, D.; Rodríguez-Rodríguez, L.; Fernández-Gutiérrez, B.; Ortiz, A. M.; González-Álvaro, I.; Gómez-Vaquero, C.; Bottini, N.; Llorca, J.; González-Gay, M. A.; Martín, J. Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients. ARTHRITIS RESEARCH & THERAPY. 2011; 13(4): R116. Article. 4,445 Q1
2011 García-Bermúdez, M.; González-Juanatey, C.; Rodríguez-Rodríguez,
L.; Miranda-Filloy, J. A.; Pérez-Esteban, S.; Vázquez-Rodríguez, T. R.;
Castaneda, S.; Balsa, A.; Fernández-Gutiérrez, B.; Llorca, J.; González-
Álvaro, I.; Martín, J.; González-Gay, M. A. Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2011; 29(4):681-688. Article.
2,148 Q3
2011 Martín, J. E.; Alizadeh, B. Z.; González-Gay, M. A.; Balsa, A.; Pascual-
Salcedo, D.; González-Escribano, M. F.; Rodríguez-Rodríguez, L.;
Fernández-Gutiérrez, B.; Raya, E.; Coenen, M. J. H.; van Riel, P.; Radstake, T. R. D. J.; Kvien, T. K.; Viken, M. K.; Lie, B. A.; Koeleman, B. P. C.; Martín, J. Evidence for PTPN22 R620W Polymorphism As the Sole Common Risk Variant for Rheumatoid Arthritis in the 1p13.2 Region. JOURNAL OF RHEUMATOLOGY. 2011; 38(11): 2290-2296. Article.
3,695 Q2
2011 López-Mejías, R.; García-Bermúdez, M.; González-Juanatey, C.; Castaneda, S.; Miranda-Filloy, J. A.; Gómez-Vaquero, C.; Fernández-Gutiérrez, B.; Balsa, A.; Pascual-Salcedo, D.; Blanco, R.; González-Álvaro, I.; Llorca, J.; Martín, J.; González-Gay, M. A. Lack of association of IL6R rs2228145 and IL6ST/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. TISSUE ANTIGENS. 2011; 78(6): 438-441. Article. 2,588 Q2
2011 de Miguel, E.; Falcao, S.; Castillo, C.; Plasencia, C.; García, M.; Branco, J. C.; Martín-Mola, E. Enthesis erosion in spondyloarthritis is not a persistent structural lesion. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(11): 2008-2010. Article. 8,727 D1
2011 de Miguel, E.; Muñoz-Fernández, S.; Castillo, C.; Cobo-Ibáñez, T.;
Martín-Mola, E. Diagnostic accuracy of enthesis ultrasound in the diagnosis of early spondyloarthritis. ANNALS OF THE RHEUMATIC DISEASES. 2011; 70(3): 434-439. Article.
8,727 D1
2010 Muñoz-Fernández.; S.; de Miguel.; E.; Cobo-Ibáñez.; T.; Carmona.; L.; Steiner.; M.; Descalzo.; M. A.; Ferreira.; A.; Balsa.; A.; Martín-Mola.; E. Early spondyloarthritis: results from the pilot registry ESPIDEP. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2010.; 28(4): 498-503. Article. 2,358 Q3
2010 Martín-Mola.; E.; Sieper.; J.; Leirisalo-Repo.; M.; Dijkmans.; B. A. C.; Vlahos.; B.; Pedersen.; R.; Koenig.; A. S.; Freundlich.; B. Sustained efficacy and safety.; including patient-reported outcomes.; with etanercept treatment over 5 years in patients with ankylosing spondylitis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2010.; 28(2): 238-245. Article. 2,358 Q3
2010 Balsa.; A.; Cabezón.; A.; Orozco.; G.; Cobo.; T.; Miranda-Carús.; E.; López-Nevot.; M. A.; Vicario.; J. L.; Martín-Mola.; E.; Martín.; J.; Pascual-Salcedo.; D. Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor. ARTHRITIS RESEARCH & THERAPY. 2010.; 12(2): R62. Article. 4,357 Q2
2010 Schoels, M.; Knevel, R.; Aletaha, D.; Bijlsma, J. W.; Breedveld, F. C.; Boumpas, D. T.; Burmester, G.; Combe, B.; Cutolo, M.; Dougados, M.; Emery, P.; van der Heijde, D.; Huizinga .T. W.; Kalden, J.; Keystone, E. C.; Kvien, T. K.; Martín-Mola, E.; Montecucco, C.; de Wit, M.; Smolen, J. S. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. ANNALS OF THE RHEUMATIC DISEASES. 2010; 69(4): 638-643. Article. 9,082 Q1
2010 Balsa, A.;. de Miguel, E.; Castillo, C.; Peiteado, D.; Martín-Mola, E.. Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard. RHEUMATOLOGY . 2010; 49(4): 683-690. Article. 4,171 Q2
2010 Conaghan, P. G.; D’Agostino, M. A.; Le Bars, M.; Baron, G.; Schmidely, N.; Wakefield, R.; Ravaud, P.; Grassi ,W.; Martín-Mola, E.; So, A.; Backhaus, M.; Malaise, M.; Emery, P.; Dougados, M. Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large.; 3-year.; prospective EULAR study. ANNALS OF THE RHEUMATIC DISEASES. 2010; ;69(4): 644-647. Article. 9,082 Q1
2010 Schoels, M.; Aletaha, D.; Smolen, J. S.; Bijlsma, J. W.; Burmester, G.; Breedveld, F. C.; Cutolo, M.; Combe B.; Dougados, M.; Emery, P.; Kalden, J.; Keystone, E. C.; Kvien, T. K.; Martín-Mola, E.; Montecucco, C.; De Wit, M. Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008. ANNALS OF THE RHEUMATIC DISEASES. 2010; 69(3): 575-578. Article. 9,082 Q1
2010 Palomino-Morales, R.; González-Juanatey, C.; Vázquez-Rodríguez, T. R.; Rodríguez, L.; Miranda-Filloy, J. A.; Pascual-Salcedo, D.; Balsa, A.; Fernández-Gutierrez, B.; Llorca, J.; Martín, J.; González-Gay, M. A. Lack of association of PTPN22.; STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2010; 28(5): 695-701. Article. 2,358 Q3
2010 Martín, J. E.; Alizadeh, B. Z.; González-Gay, M. A.; Balsa, A.; Pascual-Salcedo, D.; Fernández-Gutiérrez, B.; Raya, E.; Franke, L.; van’t Slot, R.; Coenen, M. J.; van Riel, P.; Radstake, T. R.; Koeleman, B. P.; Martín, J. Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis. ARTHRITIS AND RHEUMATISM. 2010; 62(11): 3183-3190. Article. 8,345 Q1
2010 Alonso, A.; Julià, A.; Tortosa, R.; Canaleta, C.; Cañete, J. D.; Ballina, J.; Balsa, A.; Tornero, J.; Marsal, S. CNstream: a method for the identification and genotyping of copy number polymorphisms using Illumina microarrays. BMC BIOINFORMATICS. 2010; 11: 264. Article. 3,028 Q1
2010 Robledo, G.; Rueda, B.; González-Gay, M. A.; Fernández, B.; Lamas, J. R.; Balsa, A.; Pascual-Salcedo, D.; García, A.; Raya, E.; Martín, J. Association study of ghrelin receptor gene polymorphisms in rheumatoid arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2010; 28(1): 25-29. Article. 2,358 Q3
2010 Docampo, E.; Rabionet, R.; Riveira-Muñoz, E.; Escaramís, G.; Julià, A.; Marsal, S.; Martín, J. E.; González-Gay, M. A.; Balsa, A.; Raya, E.; Martín, J.; Estivill, X. Deletion of the late cornified envelope genes.; LCE3C and LCE3B.; is associated with rheumatoid arthritis. ARTHRITIS AND RHEUMATISM. 2010; 62(5): 1246-1251. Article. 8,345 Q1
2010 Perdigones, N.; Vigo, A. G.; Lamas, J. R.; Martínez, A.; Balsa, A.; Pascual-Salcedo, D.; de la Concha, E. G.; Fernández-Gutiérrez, B.; Urcelay, E. Evidence of epistasis between TNFRSF14 and TNFRSF6B polymorphisms in patients with rheumatoid arthritis. ARTHRITIS AND RHEUMATISM. 2010; 62(3): 705-710. Article. 8,345 Q1
2010 van der Woude, D.; Lie, B. A.; Lundström, E.; Balsa, A.; Feitsma, A. L.; Houwing-Duistermaat, J. J.; Verduijn, W.; Nordang, G. B.; Alfredsson, L.; Klareskog, L.; Pascual-Salcedo, D.; González-Gay, M. A.; López-Nevot, M. A.; Valero, F.; Roep, B. O.; Huizinga, T. W,.; Kvien, T. K.; Martín, J.; Padyukov, L.; de Vries, R. R.; Toes, R. E. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. ARTHRITIS AND RHEUMATISM. 2010; 62(5): 1236-1245. Article. 8,345 Q1
2010 Balsa, A.; Del Amo, J.; Blanco, F.; Caliz, R.; Silva, L.; Sanmartí, R.; Martínez, F. G.; Tejedor, D.; Artieda, M.; Pascual-Salcedo, D.; Oreiro, N.; Collado, M. D.; Andreu, J. L.; Graell, E.; Simón, L.; Martínez, A.; Mulero, J. Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms. RHEUMATOLOGY. 2010; 49(3): 458-466. Article. 4,171 Q2
2010 Silva, L.; Miguel, E. D.; Peiteado, D.; Villalba, A.; Mola, M.; Pinto, J.; Ventura, F. S. Compliance in gout patients. ACTA REUMATOLOGICA PORTUGUESA. 2010; 35(5): 466-474. Article. 0,451 Q4
2010 Ozen, S.; Pistorio, A.; Iusan, S. M.; Bakkaloglu, A.; Herlin, T.; Brik, R.; Buoncompagni, A.; Lazar, C.; Bilge, I.; Uziel, Y.; Rigante, D.; Cantarini, L.; Hilário, M. O.; Silva, C. A.; Alegria, M.; Norambuena, X.; Belot, A.; Berkun, Y.; Estrella, A. I.; Olivieri, A. N.; Alpigiani, M. G.; Rumba, I.; Sztajnbok, F.; Tambic-Bukovac L.; Breda L.; Al-Mayouf S.; Mihaylova D.; Chasnyk V.; Sengler C.; Klein-Gitelman M.; Djeddi D.; Nuno L.; Pruunsild C.; Brunner J.; Kondi A.; Pagava K.; Pederzoli S.; Martíni A.; Ruperto N.; Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura.; childhood polyarteritis nodosa.; childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. ANNALS OF THE RHEUMATIC DISEASES. 2010; 69(5): 798-806. Article. 9,082 Q1
2010 Naredo, E.; Möller, I.; Acebes, C.; Batlle-Gualda, E.; Brito, E.; de Agustín, J. J.; de Miguel, E.; Martínez, A.; Mayordomo, L.; Moragues, C.; Rejón, E.; Rodríguez, A.; Uson, J.; Garrido, J. Three-dimensional volumetric ultrasonography. Does it improve reliabililty of musculoskeletal ultrasound? CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2010; 28(1): 79-82. Article. 2,358
Q3
2010 Fraile, J. M.; Puig, J. G.; Torres, R. J.; de Miguel, E.; Martínez, P.; Vázquez, J. J. Uric acid metabolism in patients with primary gout and the metabolic syndrome. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS. 2010; 29: 330-334. Article. 1,132
Q4
2010 Fraile, J. M.; Torres, R.; de Miguel Mendieta, E.; Martínez, P.; Lundelin, K. J.; Vázquez, J. J.; Puig, J. G. Metabolic syndrome characteristics in gout patients. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS. 2010; 29: 325-329. Article. 1,132 Q4
2010 Smolen, J. S.; Landewé, R.; Breedveld, F. C.; Dougados, M.; Emery, P.; Gaujoux-Viala, C.; Gorter, S.; Knevel, R.; Nam, J.; Schoels, M.; Aletaha, D.; Buch, M.; Gossec, L.; Huizinga, T.; Bijlsma, J. W.; Burmester, G.; Combe, B.; Cutolo, M.; Gabay, C.; Gómez-Reino, J.; Kouloumas, M.; Kvien, T. K.; Martín-Mola, E.; McInnes, I.; Pavelka, K.; van Riel, P.; Scholte, M.; Scott, D. L.; Sokka, T.; Valesini, G.; van Vollenhoven, R.; Winthrop, K. L.; Wong, J.; Zink, A.; van der Heijde, D. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. ANNALS OF THE RHEUMATIC DISEASES. 2010.; 69(6): 964-975. Review. 9,082 Q1
2010 Smolen, J. S.; Aletaha, D.; Bijlsma, J. W.; Breedveld, F. C.; Boumpas, D.; Burmester, G.; Combe, B.; Cutolo, M.; de Wit, M.; Dougados, M.; Emery, P.; Gibofsky, A.; Gómez-Reino, J. J.; Haraoui, B.; Kalden, J.; Keystone, E. C.; Kvien, T. K.; McInnes, I.; Martín-Mola, E.; Montecucco, C.; Schoels, M.; van der Heijde D.; T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. ANNALS OF THE RHEUMATIC DISEASES. 2010; 69(4): 631-637. Review. 9,082 Q1
2009 Falcao, S; Gamero, F; de Miguel, E; Mourao, AF; Pimentiao, JB; Branco, JC; Mola, EM. Foreign body reaction to palm leaf. ACTA REUMATOLOGICA PORTUGUESA. 2009; 34(1): 136-137 0,726
Q4
2009 Videira, T; De Miguel, E; Ventura, FS; Mola, EM. Hip arthritis in an young adult - a diagnosis to consider. ACTA REUMATOLOGICA PORTUGUESA. 2009; 34(4): 651-655 0,726
Q4
2009 Monteiro, P; de Miguel, E; Mola, EM. Musculoskeletal ultrasonography in rheumatology. ACTA REUMATOLOGICA PORTUGUESA. 2009; 34(2B): 388-394 0,726
Q4
2009 Teixeira, VH; Dieude, P; Michou, L; Migliorini, P; Balsa, A; Westhovens, R; Barrera, P; Alves, H; Vaz, C; Fernandes, M; Pascual-Salcedo, D; Bombardieri, S; Dequeker, J; Radstake, TR; Van Riel, P; van de Putte, L; Lopes-Vaz, A; Bardin, T; Cornelis, F; Petit-Teixeira, E. Association study of the RANK locus in white European rheumatoid arthritis families. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(3): 448-449 8,111
Q1
2009 Gossec, L; Dougados, M; Rincheval, N; Balanescu, A; Boumpas, DT; Canadelo, S; Carmona, L; Daures, JP; de Wit, M; Dijkmans, BAC; Englbrecht, M; Gunendi, Z; Heiberg, T; Kirwan, JR; Mola, EM; Matucci-Cerinic, M; Otsa, K; Schett, G; Sokka, T; Wells, GA; Aanerud, GJ; Celano, A; Dudkin, A; Hernandez, C; Koutsogianni, K; Akca, FN; Petre, AM; Richards, P; Scholte-Voshaar, M; Von Krause, G; Kvien, TK. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(11): 1680-1685 8,111
Q1
2009 Zhang, W; Doherty, M; Leeb, BF; Alekseeva, L; Arden, NK; Bijlsma, JW; Dincer, F; Dziedzic, K; Hauselmann, HJ; Kaklamanis, P; Kloppenburg, M; Lohmander, LS; Maheu, E; Martin-Mola, E; Pavelka, K; Punzi, L; Reiter, S; Smolen, J; Verbruggen, G; Watt, I; Zimmermann-Gorska, I. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(1): 8-17 8,111
Q1
2009 Dieguez-Gonzalez, R; Akar, S; Calaza, M; Perez-Pampin, E; Costas, J; Torres, M; Vicario, JL; Velloso, ML; Navarro, F; Narvaez, J; Joven, B; Herrero-Beaumont, G; Gonzalez-Alvaro, I; Fernandez-Gutierrez, B; de la Serna, AR; Carreno, L; Lopez-Longo, J; Caliz, R; Collado-Escobar, MD; Blanco, FJ; Fernandez-Lopez, C; Balsa, A; Pascual-Salcedo, D; Gomez-Reino, JJ; Gonzalez, A. Genetic variation in the nuclear factor kappa B pathway in relation to susceptibility to rheumatoid arthritis. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(4): 579-583 8,111
Q1
2009 van der Heijde, D; Burmester, G; Melo-Gomes, J; Codreanu, C; Mola, EM; Pedersen, R; Robertson, D; Chang, D; Koenig, A; Freundlich, B. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(7): 1113-1118 8,111
Q1
2009 Visser, K; Katchamart, W; Loza, E; Martinez-Lopez, JA; Salliot, C; Trudeau, J; Bombardier, C; Carmona, L; van der Heijde, D; Bijlsma, JWJ; Boumpas, DT; Canhao, H; Edwards, CJ; Hamuryudan, V; Kvien, TK; Leeb, BF; Martin-Mola, EM; Mielants, H; Muller-Ladner, U; Murphy, G; Ostergaard, M; Pereira, IA; Ramos-Remus, C; Valentini, G; Zochling, J; Dougados, M. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(7): 1086-1093 8,111
Q1
2009 de Miguel, E; Cobo, T; Munoz-Fernandez, S; Naredo, E; Uson, J; Acebes, JC; Andreu, JL; Martin-Mola, E. Validity of enthesis ultrasound assessment in spondyloarthropathy. ANNALS OF THE RHEUMATIC DISEASES. 2009; 68(2): 169-174 8,111
Q1
2009 Munoz-Fernandez, S; de Miguel, E; Cobo-Ibanez, T; Madero, R; Ferreira, A; Hidalgo, MV; Schlincker, A; Martin-Mola, E. Enthesis Inflammation in Recurrent Acute Anterior Uveitis Without Spondylarthritis. ARTHRITIS AND RHEUMATISM. 2009; 60(7): 1985-1990 4,152
Q2
2009 Suarez-Gestal, M; Calaza, M; Dieguez-Gonzalez, R; Perez-Pampin, E; Pablos, JL; Navarro, F; Narvaez, J; Marenco, JL; Herrero-Beaumont, G; Fernandez-Gutierrez, B; Lamas, JR; de la Serna, AR; Ortiz, AM; Carreno, L; Canete, JD; Caliz, R; Blanco, FJ; Balsa, A; Gomez-Reino, JJ; Gonzalez, A. Rheumatoid Arthritis Does Not Share Most of the Newly Identified Systemic Lupus Erythematosus Genetic Factors. ARTHRITIS AND RHEUMATISM. 2009; 60(9): 2558-2564 4,152
Q2
2009 Rozco, G; Abelson, AK; Gonzalez-Gay, MA; Balsa, A; Pascual-Salcedo, D; Garcia, A; Fernandez-Gutierrez, B; Petersson, I; Pons-Estel, B; Eimon, A; Paira, S; Scherbarth, HR; Alarcon-Riquelme, M; Martin, J. Study of Functional Variants of the BANK1 Gene in Rheumatoid Arthritis. ARTHRITIS AND RHEUMATISM. 2009; 60(2): 372-379 4,152
Q2
2009 Dieguez-Gonzalez, R; Calaza, M; Perez-Pampin, E; Balsa, A; Blanco, FJ; Canete, JD; Caliz, R; Carreno, L; de la Serna, AR; Fernandez-Gutierrez, B; Ortiz, AM; Herrero-Beaumont, G; Pablos, JL; Narvaez, J; Navarro, F; Marenco, JL; Gomez-Reino, JJ; Gonzalez, A. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappa B and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility. ARTHRITIS RESEARCH & THERAPY. 2009; 11(2): R42 4,271
Q1
2009 Sanmarti, R; Graell, E; Perez, ML; Ercilla, G; Vinas, O; Gomez-Puerta, JA; Gratacos, J; Balsa, A; Gomara, MJ; Larrosa, M; Canete, JD; Haro, I. Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis. ARTHRITIS RESEARCH & THERAPY. 2009; 11(5): R135 4,271
Q1
2009 Teixeira, VH; Pierlot, C; Migliorini, P; Balsa, A; Westhovens, R; Barrera, P; Alves, H; Vaz, C; Fernandes, M; Pascual-Salcedo, D; Bombardieri, S; Dequeker, J; Radstake, TR; Van Riel, P; van de Putte, L; Lopes-Vaz, A; Bardin, T; Prum, B; Cornelis, F; Petit-Teixeira, E. Testing for the association of the KIAA1109/Tenr/IL2/IL21 gene region with rheumatoid arthritis in a European family-based study. ARTHRITIS RESEARCH & THERAPY. 2009; 11(2): R45 4,271
Q1
2009 Munoz-Fernandez, S; Garcia-Aparicio, AM; Hidalgo, MV; Platero, M; Schlincker, A; Bascones, ML; Pombo, M; Morente, P; Sanpedro, J; Martin-Mola, E. Methotrexate: an option for preventing the recurrence of acute anterior uveitis. EYE. 2009; 23(5): 1130-1133 1,974
Q2
2009 Benito-Miguel, M; Garcia-Carmona, Y; Balsa, A; de Ayala, CP; Cobo-Ibanez, T; Martin-Mola, E; Miranda-Carus, ME. A Dual Action of Rheumatoid Arthritis Synovial Fibroblast IL-15 Expression on the Equilibrium between CD4(+)CD25(+) Regulatory T Cells and CD4(+)CD25(-) Responder T Cells. JOURNAL OF IMMUNOLOGY. 2009; 183(12): 8268-8279 5,646
Q1
2009 Dijkmans, B; Emery, P; Hakala, M; Leirisalo-Repo, M; Mola, EM; Paolozzi, L; Salvarani, C; Sanmarti, R; Sibilia, J; Sieper, J; Van den Bosch, F; van der Heijde, D; van der Linden, S; Wajdula, J. Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis. JOURNAL OF RHEUMATOLOGY. 2009; 36(6): 1256-1264 3,854
Q2
2009 Maillefert, JF; Kloppenburg, M; Fernandes, L; Punzi, L; Gunther, KP; Mola, EM; Lohmander, LS; Pavelka, K; Lopez-Olivo, MA; Dougados, M; Hawker, GA. Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP). OSTEOARTHRITIS AND CARTILAGE. 2009; 17(10): 1293-1296 3,888
Q1
2009 Martin-Mola, E; Balsa, A. Infectious Complications of Biologic Agents. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. 2009; 35(1): 183 2,594
Q2